|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.520 USD | +5.56% |
|
-9.52% | -75.16% |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 36.37M 31.79M 29.22M 27.23M 51.65M 3.46B 52.44M 351M 136M 1.7B 137M 134M 5.87B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 36.37M 31.79M 29.22M 27.23M 51.65M 3.46B 52.44M 351M 136M 1.7B 137M 134M 5.87B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
84.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Actuate Therapeutics, Inc.
| 1 day | +5.56% | ||
| 1 week | -9.52% | ||
| Current month | -0.65% | ||
| 1 month | -19.15% | ||
| 3 months | -38.71% | ||
| 6 months | -76.03% | ||
| Current year | -75.16% |
| 1 week | 1.4 |  | 1.63 |
| 1 month | 1.4 | | 2.78 |
| Current year | 1.4 | | 7.05 |
| 1 year | 1.4 | | 9.22 |
| 3 years | 1.4 | | 11.99 |
| 5 years | 1.4 | | 11.99 |
| 10 years | 1.4 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 2015-02-28 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 2024-01-31 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 2015-03-31 |
Aaron Fletcher
CHM | Chairman | 46 | 2015-03-31 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 2021-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-20 | Free | Director | 15,000 | 0.0633% | ||
| 05-20 | Free | Director | 15,000 | 0.0633% | ||
| 05-20 | Free | Director | 15,000 | 0.0633% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.56% | -9.52% | -76.93% | - | 36.37M | |
| +0.68% | +5.92% | +77.86% | +136.97% | 59.1B | |
| +2.32% | +5.03% | +75.26% | +92.31% | 55.19B | |
| +3.86% | +6.93% | -11.32% | -10.57% | 24.67B | |
| +4.30% | +7.95% | +14.11% | +440.44% | 24.19B | |
| +4.74% | +13.68% | +43.36% | -3.82% | 19.69B | |
| -0.29% | +9.78% | +43.90% | -29.12% | 17.56B | |
| 0.00% | +20.78% | +186.15% | +347.42% | 16.22B | |
| +6.72% | +19.38% | +37.85% | - | 14.84B | |
| +3.50% | +1.97% | +21.02% | +193.33% | 14.04B | |
| Average | +3.14% | +5.46% | +41.12% | +145.87% | 24.55B | |
| Weighted average by Cap. | +2.46% | +6.47% | +58.30% | +135.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$1.520 | +5.56% | 179,886 |
| 26-07-01 | US$1.440 | -5.88% | 135,777 |
| 26-06-30 | US$1.530 | -3.16% | 116,517 |
| 26-06-29 | US$1.580 | -5.95% | 197,295 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.520USD
Average target price
9.978USD
Spread / Average Target
+556.41%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
